Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 01, 2018
Source ID
10.1074/jbc.ra117.000940

Entities

People

  • Fen Wang
  • Houjian Cai
  • Iryna Lebedyeva
  • Junchen Liu
  • Kebin Liu
  • Omar Awad Alsaidan
  • Qianjin Li
  • Shaying Zhao
  • Sung Jin Kim
  • Thomas Albers
  • Yongjie Ma
  • Zanna Beharry

Organizations

  • National Institutes of Health
  • United States Department of Defense